Results 31 to 40 of about 283,560 (208)

Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences

PLoS ONE, 2019
Background Hepatitis B is a global health problem. Trainees in the health-related fields are exposed to occupational risk of Hepatitis B Virus. In Uganda, there is scarcity of information on vaccination among students in health-care.
Yvette Wibabara, C. Banura, J. Kalyango, C. Karamagi, A. Kityamuwesi, W. Amia, P. Ocama   +6 more
semanticscholar   +1 more source

Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey

PLoS ONE, 2019
Background In Malaysia, one million individuals are estimated to be infected with the hepatitis B virus. A vaccine for infants has been compulsory since 1989, whereas those born before 1989 need to spend their own money to be vaccinated in private ...
Y. Rajamoorthy, A. Radam, N. Taib, K. Rahim, Subramaniam Munusamy, A. Wagner, M. Mudatsir, Abdullatif Bazrbachi, H. Harapan   +8 more
semanticscholar   +1 more source

Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much, who and why?

BMC Infectious Diseases, 2017
BackgroundHepatitis B vaccination for healthcare workers (HCWs) is a key component of the WHO Hepatitis B Elimination Strategy 2016–2021. Data on current hepatitis B vaccine coverage among health care workers in Sub-Saharan Africa are scarce, but these ...
D. Aaron, Tumaini J. Nagu, John Rwegasha, E. Komba   +3 more
semanticscholar   +1 more source

The role of provider characteristics on the hepatitis A and B vaccination status of adults in the United States during 2007–2015

Preventive Medicine Reports, 2019
Hepatitis A and B vaccine coverage is suboptimal in US adults, even among those at increased risk for infection, morbidity, or mortality. To understand where medical education and resources might enhance vaccine coverage, it is important to first ...
P.K. Ghaswalla, B.J. Patterson, W.Y. Cheng, E. Duchesneau, M. Macheca, M.S. Duh, A.F. Trofa   +6 more
doaj   +1 more source

Seroprevalence of Hepatitis B Viral Markers Among Freshmen — 20 Years After Mass Hepatitis B Vaccination Program in Taiwan

Journal of the Formosan Medical Association, 2007
The nationwide hepatitis B vaccination program in Taiwan was well known for its efficacy in reducing the carrier rate of hepatitis B and the morbidity and mortality of hepatitis B-related diseases among children.
Hsien-Cheng Chang, Chung-Jen Yen, Yi-Chin Lee, Tai-Yuan Chiu, Chyi-Feng Jan   +4 more
doaj   +1 more source

Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

Journal of Viral Hepatitis, 2019
The duration of protection after hepatitis B vaccination is not exactly known. This phase IV study evaluated antibody persistence and immune memory 20‐30 years after adult immunization with recombinant hepatitis B vaccine (HBsAg vaccine, Engerix‐B) in ...
P. van Damme, M. Dionne, G. Leroux-Roels, O. Van Der Meeren, Emmanuel Di Paolo, B. Salaun, Pemmaraju Surya Kiran, N. Folschweiller   +7 more
semanticscholar   +1 more source

Current situation, challenges, and future prospects of hepatitis B vaccination in China: a review

Zhongguo gonggong weisheng
It is about to enter the decisive five years of the 2030 goal set by the World Health Organization to eliminate hepatitis. As one of the countries with the heaviest burden of hepatitis B virus, China faces self-evident challenges. Hepatitis B vaccination
Chengbin SHI, Jiaxin XIE, Jiamin QIU, Xiaoping SHAO, Fangfang ZENG, Xiaofeng LIANG   +5 more
doaj   +1 more source

Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030

Vaccines
Annually, more than 1.5 million preventable new hepatitis B (HBV) infections continue to occur, with an estimated global burden of 296 million individuals living with chronic hepatitis B infection.
Said A. Al-Busafi, Ahmed Alwassief
semanticscholar   +1 more source

Hepatitis B vaccine development and implementation

Human Vaccines & Immunotherapeutics, 2020
Vaccination against hepatitis B is the most effective strategy to control HBV infection. The first licensed hepatitis B vaccine was developed by the purification of hepatitis B surface antigen (HBsAg) from plasma of asymptomatic HBsAg carriers. Then, the
Hong Zhao, Xiaoying Zhou, Yi-Hua Zhou
doaj   +1 more source

Interventions to Increase Completion of Hepatitis B Vaccination in People who Inject Drugs: A Systematic Review and Meta-analysis

Open Forum Infectious Diseases, 2019
Increases in opioid misuse and injection drug use have resulted in a rise in acute cases of hepatitis B. We conducted a systematic review and meta-analysis of randomized studies to determine the effect (pooled odds ratio) of interventions to increase ...
Stacy R. Tressler, R. Bhandari
semanticscholar   +1 more source